<DOC>
	<DOCNO>NCT01972126</DOCNO>
	<brief_summary>The MAGNetic QRS-Fragmentation Patients Myocardial InfarcTion Moderately RedUceD Ejection Fraction ( MAGNITUDE ) study assess MI survivor moderately reduce left ventricular function , whether non-invasive MFI QRS Fragmentation alone combination parameter derive Holter record use identify group patient high risk SCD/life threaten ventricular arrhythmia .</brief_summary>
	<brief_title>MAGNetic QRS-Fragmentation Patients With Myocardial InfarcTion Moderately RedUceD Ejection Fraction</brief_title>
	<detailed_description>Cardiac disease common cause natural death Western hemisphere . Half cardiac death sudden , arrhythmic . Myocardial infarction ( MI ) survivor four five-fold high risk SCD compare person without history MI . Current risk assessment approach fail identify majority patient risk sudden , arrhythmic death . Given fact , patient population represent relevant proportion total population risk develop sudden death currently indicate preventive therapy . The post-MI population moderate LV function , specifically Left Ventricular Ejection Fraction ( LVEF ) 35 % 50 % , therefore appropriate group ass SCD prevention strategy . It show increase QRS fragmentation assess Magnetic Field Imaging ( MFI ) correlate high incidence arrhythmic death . MAGNITUDE prospective , multicenter , non-interventional , observational cohort study , provide detailed information event rate MFI threshold prediction SCD/life threaten cardiac arrhythmic event . Target enrollment 1000 patient , enrollment may extend minimally 24 event accrue ( maximum 1500 patient ) . All patient follow least 12 month enrollment closure , follow-up duration may extend minimally 40 event accrue . Interim analysis perform 10 , 20 30 event , also 40 event milestone reach 6 month end follow-up . Final analysis do end follow-up .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>1 . Patients must provide write informed consent/data release consent participate study 2 . Acute Myocardial Infarction ( STEMI nonSTEMI ) within last 310 day match follow criterion : Rise and/or fall Troponin ( I T ) cardiac specific creatine kinase ( CKMB ) least one value 99th percentile upper reference limit measure plus least one following : 1 . Chest pain â‰¥ 20 minute 2 . STsegment elevation &gt; 0.1mV two limb lead &gt; 0.2 mV two contiguous precordial lead new left bundle branch block ( LBBB ) ECG 3 . Development new pathological Q wave ECG 3 . LVEF = 36 % 50 % measure standard diagnostic method use center 4 . MFI assessment , acquire plan BMDSys Apollo CXS system 1 . Age &lt; 18 year 2 . Legally incapacitated 3 . Contraindication MFI measurement : 1 . Preexisting electrically active implant 2 . Required electrical external support system remove MFI scan 4 . Other disease ; likely limit survival less minimal study duration ( 12 month ) 5 . Participation another investigational study know suspected cardiac effect expect confound result study ( e.g . Stem cell trial , stent trial , cardiac intervention trial ) 6 . Existing ICD pacemaker indication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>